PTJ
ACRS icon

Paul Tudor Jones’s Aclaris Therapeutics ACRS Stock Holding History

Paul Tudor Jones’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33,183
Closed -$38.2K – 2955
2024
Q3 		$38.2K Hold
33,183
– – ﹤0.01% 2624
2024
Q2 		$36.5K Hold
33,183
– – ﹤0.01% 2237
2024
Q1 		$41.1K Hold
33,183
– – ﹤0.01% 2121
2023
Q4 		$34.8K Hold
33,183
– – ﹤0.01% 2275
2023
Q3 		$227K Buy
33,183
+1
+0% +$9 ﹤0.01% 2034
2023
Q2 		$344K Buy
33,182
+2,038
+7% +$18.4K ﹤0.01% 1922
2023
Q1 		$252K Buy
+31,144
New +$395K ﹤0.01% 2046
2022
Q3 		– Sell
-12,090
Closed -$169K – 2261
2022
Q2 		$169K Buy
+12,090
New +$169K ﹤0.01% 1861
2021
Q4 		– Sell
-10,539
Closed -$190K – 2317
2021
Q3 		$190K Buy
+10,539
New +$169K ﹤0.01% 2318
2020
Q4 		– Sell
-20,750
Closed -$53K – 1305
2020
Q3 		$53K Sell
20,750
-37,976
-65% -$85K ﹤0.01% 1211
2020
Q2 		$95K Hold
58,726
– – ﹤0.01% 1089
2020
Q1 		$61K Sell
58,726
-200
-0.3% -$272 0.01% 960
2019
Q4 		$111K Hold
58,926
– – 0.01% 1047
2019
Q3 		$64K Buy
+58,926
New +$83.6K ﹤0.01% 1023
2019
Q1 		– Sell
-12,906
Closed -$95K – 1080
2018
Q4 		$95K Buy
+12,906
New +$133K ﹤0.01% 928
2018
Q1 		– Sell
-12,296
Closed -$303K – 973
2017
Q4 		$303K Buy
+12,296
New +$299K 0.01% 794

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Paul Tudor Jones's ACRS Position: Q4 2024 in Review

Paul Tudor Jones sold out of Aclaris Therapeutics (ACRS) in Q4 2024, closing a stake of 33,183 shares — an estimated $38.2K sold.

Paul Tudor Jones first reported a position in ACRS in Q4 2017 and held it in 16 quarters. The position peaked at $344K in Q2 2023. 98 funds tracked by Wall St. Rank hold ACRS as of Q4 2024.

  • Paul Tudor Jones reported no remaining Aclaris Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 33,183 Aclaris Therapeutics shares in Q4 2024, an estimated $38.2K.
  • Paul Tudor Jones first reported a position in Aclaris Therapeutics in Q4 2017 and held it in 16 quarters.
  • Paul Tudor Jones's Aclaris Therapeutics position peaked at $344K in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.